BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6973861)

  • 1. Alloantibodies reacting exclusively with PHA-activated T lymphocytes.
    Christiansen FT; Kim SJ; Gosar I; Silver DM; Pollack MS; Dupont B
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1189-92. PubMed ID: 6973861
    [No Abstract]   [Full Text] [Related]  

  • 2. Alloantibodies to PHA-activated lymphocytes detect human Qa-like antigens.
    Gazit E; Gothelf Y; Gil R; Orgad S; Pitman TB; Watson AL; Yang SY; Yunis EJ
    J Immunol; 1984 Jan; 132(1):165-9. PubMed ID: 6606664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of alloantibodies reacting with PHA-activated T lymphocytes, unexplainable by known HLA activities.
    Kim SJ; Christiansen FT; Gosar I; Silver DM; Pollack MS; Dupont B
    Hum Immunol; 1980 Dec; 1(4):347-55. PubMed ID: 6973560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the detectability of HLA antigens on lymphocyte subpopulations induced by mitogens and corticosteroids].
    Volgin AIu; Pevnitskiĭ LA
    Biull Eksp Biol Med; 1982 Jan; 93(1):45-7. PubMed ID: 6978158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 activated lymphocytes show improved sensitivity for class 1 HLA typing.
    Hirose M; Shinohara K; Watanabe H; Lee E; Kuroda Y
    Tokushima J Exp Med; 1996 Dec; 43(3-4):87-91. PubMed ID: 9100455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human alloantiserum against PHA-activated cells. Cytotoxicity associated with the HLA-A3 antigen.
    Bućin D; Löw B
    Tissue Antigens; 1985 Jan; 25(1):50-4. PubMed ID: 3872487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional significance of Tac antigen expressed on activated human T lymphocytes: Tac antigen interacts with T cell growth factor in cellular proliferation.
    Miyawaki T; Yachie A; Uwadana N; Ohzeki S; Nagaoki T; Taniguchi N
    J Immunol; 1982 Dec; 129(6):2474-8. PubMed ID: 6982926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level of Ia-like antigens on human B and T lymphocytes.
    Wilson BS; Indiveri F; Quaranta V; Pellegrino MA; Ferrone S
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1033-4. PubMed ID: 6973853
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific IgG autoantibodies are potent inhibitors of autoreactive T cell response to phytohemagglutinin-activated T cells.
    Wolf-Levin R; Azuma T; Aoki K; Yagami Y; Okada H
    J Immunol; 1993 Nov; 151(10):5864-77. PubMed ID: 8228265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular specificities of lymphocytotoxic alloantibodies from sensitized chronic renal failure patients.
    Sidgwick A; Horsburgh T; Bell PR
    Transplant Proc; 1987 Feb; 19(1 Pt 1):773-4. PubMed ID: 3274870
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigen-presenting properties of human vascular endothelial cells: inhibition by anti-HLA-DR antisera.
    Hirschberg H; Hirschberg T; Jaffe E; Thornsby E
    Scand J Immunol; 1981 Nov; 14(5):545-53. PubMed ID: 6977827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological reactivity of patients with simple psoriasis. I. Delayed hypersensitivity to phytohemagglutinin].
    Kapińska-Mrówka M; Turowski G
    Przegl Dermatol; 1980; 67(6):715-21. PubMed ID: 6972550
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the cellular requirements for human T cell transformation by a soluble mitogen derived from Mycoplasma arthritidis and concanavalin A.
    Daynes RA; Novak JM; Cole BC
    J Immunol; 1982 Sep; 129(3):936-8. PubMed ID: 6980925
    [No Abstract]   [Full Text] [Related]  

  • 15. Alloantisera with apparent HLA-A specificity reacting only against phytohemagglutinin-activated cells.
    Crepaldi T; Amoroso A; Curtoni ES; Richiardi P
    Ric Clin Lab; 1986; 16(3):449-56. PubMed ID: 2433726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N; Pirsch J; Samaniego M
    Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastogenic response of activated human umbilical cord blood T-lymphocytes.
    D'Arena G; Cascavilla N; Carotenuto M
    Haematologica; 1998 Nov; 83(11):1048-50. PubMed ID: 9864931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction.
    Di Ianni M; Casciari C; Ciurnelli R; Fulvi A; Bagnis C; Lucheroni F; Falzetti F; Mannoni P; Martelli MF; Tabilio A
    Haematologica; 1996; 81(5):410-7. PubMed ID: 8952153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulous humors: defining alloantibodies in the 21st century.
    Warner P
    Hum Immunol; 2009 Aug; 70(8):623-6. PubMed ID: 19374934
    [No Abstract]   [Full Text] [Related]  

  • 20. Rabbit B spleen lymphocytes and macrophages as accessory cells in T-cell activation by mitogens.
    Cavaillon JM; Udupa TN; Chou CT; Cinader B; Dubiski S
    Ann Immunol (Paris); 1981; 132D(1):65-76. PubMed ID: 6982021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.